Iovance Biotherapeutics Inc (NASDAQ:IOVA)

22.90
Delayed Data
As of 4:00pm ET
 -0.97 / -4.06%
Today’s Change
7.26
Today|||52-Week Range
26.59
+158.76%
Year-to-Date
3 Cancer Treatment Stocks to Buy Right Now
Nov 09 / MotleyFool.com - Paid Partner Content
Iovance Biotherapeutics, Inc. (IOVA) Q3 2019 Earnings Call Transcript
Nov 04 / MotleyFool.com - Paid Partner Content
Why Iovance Biotherapeutics Shares Are Soaring Today
Nov 08 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close23.87
Today’s open23.86
Day’s range22.84 - 24.19
Volume1,359,590
Average volume (3 months)1,286,387
Market cap$3.0B
Data as of 4:00pm ET, 11/12/2019

Growth & Valuation

Earnings growth (last year)+9.90%
Earnings growth (this year)-18.11%
Earnings growth (next 5 years)-19.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.25

Competitors

 Today’s
change
Today’s
% change
CRSPCRISPR Therapeutics ...+2.67+5.24%
EBSEmergent BioSolution...+1.58+2.94%
ALLOAllogene Therapeutic...-0.49-1.80%
IMMUImmunomedics Inc+0.20+1.16%
Data as of 6:30pm ET, 11/12/2019

Financials

Next reporting dateMarch 6, 2020
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$0.00
Annual profit (last year)-$123.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Carlos, California

Forecasts